Page 12 - பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை Today - Breaking & Trending Today

Personalized cancer vaccine is safe, shows potential benefit against cancer


 E-Mail
New York, NY (April 10, 2021) - A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15.
While immunotherapy has revolutionized the treatment of cancer, the vast majority of patients do not experience a significant clinical response with such treatments, said study author Thomas Marron, MD, PhD, Assistant Director for Early Phase and Immunotherapy Trials at The Tisch Cancer Institute and Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. Cancer vaccines, which typically combine tumor-specific targets that the immune system ....

New York , United States , Long Island , Nina Bhardwaj , Thomas Marron , Health System , Tisch Cancer Institute , Tisch Cancer Institute At Mount Sinai , Cancer Research , American Association For Cancer Research , Icahn School Of Medicine At Mount Sinai , Immunotherapy Program , Parker Institute For Cancer Immunotherapy , Mount Sinai Health System , Icahn School Of Medicine , Mount Sinai , American Association , Annual Meeting , Assistant Director , Early Phase , Assistant Professor , Medical Oncology , Icahn School , Ward Coleman Chair , Parker Institute , Tisch Cancer ,